logo BDSP

Base documentaire

  1. Human immunodeficiency virus and hepatitis B virus seroprevalence in an urban trauma population.

    Article, Communication - En anglais

    Conference on AIDS, hepatitis, and blood-borne diseases. Altanta GA USA, 1992/03.


    To determine the seroprevalence of the human immunodeficiency virus (HIV) and the hepatitis B virus (HBV) in patients of an urban level I trauma center.


    Prospective, blinded point prevalence study of serum HIV and HBV antibody and antigen.


    An urban level I trauma center that participates in a trauma system serving three million people.


    The study included 994 (94.8%) of 1049 consecutive trauma service patients treated between June 6,1988 and September 22,1988.


    Young urban trauma patients, because of drug-related intentional violence, are 15.3 to 17.6 times more likely to be HIV infected and 3.9 to 7.9 times more likely to be infectious for HIV or HBV than the trauma population overall.

    The 12 to 21% infection rates in critically injured patients who require shock resuscitation and/or die reinforces the need for mandated universal precautions and for clear policies which govern the performance of procedures by physicians in training.

    Primary HIV infection in critically injured patients may worsen their outcome and may adversely affect the exposed health care worker.

    Emergency departments and trauma units should develop a referral system to HIV primary care services (HIV counselling and testing) for high risk patients and for adversely exposed health care workers.

    Mots-clés Pascal : Traumatisme, Homme, Association, Illinois, Etats Unis, Amérique du Nord, Amérique, Epidémiologie, SIDA, Virose, Infection, Prévalence, Service hospitalier, Hépatite virale B, Immunopathologie, Immunodéficit, Appareil digestif pathologie, Foie pathologie

    Mots-clés Pascal anglais : Trauma, Human, Association, Illinois, United States, North America, America, Epidemiology, AIDS, Viral disease, Infection, Prevalence, Hospital ward, Viral hepatitis B, Immunopathology, Immune deficiency, Digestive diseases, Hepatic disease

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 95-0350729

    Code Inist : 002B16N. Création : 01/03/1996.